Neuro-Oncology Reviews

Volume 27 Number 36
31 December 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 36, 31 December

Gerritsen JKW, Karschnia P, Bello L, Hervey-Jumper S, Young JS, Seidel K, Satoer DD, Schnell O, Parsons M, Nahed BV, Menna G, Teske N; External Rater Panel; Smith TR, Sanai N, Krieg SM, Schucht P, Broekman MLD, De Vleeschouwer S, Jakola AS, van den Bent MJ, Chang SM, Vogelbaum MA, Vincent AJPE, Tonn JC, Berger MS.
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making.
Lancet Oncol. 2025 Dec 22;27(1):e11-e23. doi: 10.1016/S1470-2045(25)00531-5. PMID: 41449153. Guidelines˰ ˍ

Gerritsen JKW, Karschnia P, Bello L, Hervey-Jumper S, Young JS, Seidel K, Satoer DD, Schnell O, Parsons M, Nahed BV, Menna G, Teske N; External Rater Panel; Smith TR, Sanai N, Krieg SM, Schucht P, Broekman MLD, De Vleeschouwer S, Jakola AS, van den Bent MJ, Chang SM, Vogelbaum MA, Vincent AJPE, Tonn JC, Berger MS.
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment.
Lancet Oncol. 2025 Dec 22;27(1):e24-e32. doi: 10.1016/S1470-2045(25)00532-7. PMID: 41449155. Guidelines˰ ˍ

Russano F, Sturlese M, Dall'Olmo L, Callegarin F, Brugnolo D, Del Fiore P, Patti V, Purpura A, Moro S, Rastrelli M, Mocellin S.
MDM2 in Tumor Biology and Cancer Therapy: A Review of Current Clinical Trials.
Int J Mol Sci. 2025 Dec 22;27(1):99. doi: 10.3390/ijms27010099. PMID: 41515979. Review. ˍ

Spiró Z, El-Heliebi A, Mair MJ, Pieber TR, Prietl B, Spiegl-Kreinecker S, Stanzer S, Wöhrer A, Preusser M, Berghoff AS.
Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges.
Cancer Treat Rev. 2025 Dec 22;143:103072. doi: 10.1016/j.ctrv.2025.103072. PMID: 41475298. Review. ˍ

Cui S, Guan F, Li X, Long X, Wu M.
Astrocytes in glioblastoma tumor microenvironment.
Biochim Biophys Acta Rev Cancer. 2025 Dec 23;1881(1):189518. doi: 10.1016/j.bbcan.2025.189518. PMID: 41448554. Review˰ ˍ

Li B, Xi W, Li P.
Cytotoxic T lymphocytes and their dual role in modulating blood-brain barrier integrity in immune-mediated neurological pathologies.
J Transl Med. 2025 Dec 23. doi: 10.1186/s12967-025-07288-3. PMID: 41437267. Review. ˍ

Agarwal S.
Cancer neuroscience: illuminating the neural dimension of tumor biology.
Sci Rep. 2025 Dec 24;15(1):44406. doi: 10.1038/s41598-025-31931-0. PMID: 41436803. Editorial. ˍ

Stepniak A, Diamandi J, Shanahan RM, Garcia J, Qazi Z, Cabral DTF, Agarwal N, Hamilton DK.
Mapping influence in pediatric craniopharyngioma: the 50 most cited articles.
Childs Nerv Syst. 2025 Dec 25;41(1):432. doi: 10.1007/s00381-025-07071-1. PMID: 41447417. Bibliometric analysis˰ ˍ

Agosti E, Panciani PP, Lombardi G, Preusser M, Rosa G, Mapelli K, Piazza A, Tognetto D, Gagliano C, Denaro L, Padovan M, Fontanella MM, Zeppieri M, Ius T.
Targeted therapies in optic pathway gliomas.
Cancer Treat Rev. 2025 Dec 27;143:103073. doi: 10.1016/j.ctrv.2025.103073. PMID: 41478004. Review. ˍ

Jia JL, Alshamsan B, Beltran-Bless A, MacRae M, Rose F, Leigh J, Chowdhury D, Fazzari F, Lo V, Lee SF, Ng TL.
Pneumocystis jirovecii pneumonia prophylaxis in patients with glioma receiving concurrent chemoradiation: a systematic review and meta-analysis.
EClinicalMedicine. 2025 Dec 27;91:103715. doi: 10.1016/j.eclinm.2025.103715. PMID: 41542224. Review; Meta-analysis. ˍ

Cueto-Ureña C, Ramírez-Expósito MJ, Martínez-Martos JM.
Neuron-Glioma Synapses in Tumor Progression.
Biomedicines. 2025 Dec 29;14(1):72. doi: 10.3390/biomedicines14010072. PMID: 41595608. Review. ˍ

Liu J, Ha JH, Abikenari M, Sjoholm MA, Annagiri S, Ravi K, Bergsneider BH, Verma R, Theodros D, Medikonda R, Li G, Prolo LM, Monje M, Lim M.
Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation.
J Neurooncol. 2025 Dec 29;176(2):144. doi: 10.1007/s11060-025-05347-9. PMID: 41460355. Review. ˍ

St Brice K, Parker T, Wouters K, Guzmán-Ríos ED, Marciscano AE, Wang N, Dietrich J, Choi BD, Nahed BV.
Extent of resection and adjuvant treatment in adult cerebellar glioblastoma: systematic review and meta-analysis of survival outcomes.
J Neurooncol. 2025 Dec 29;176(2):138. doi: 10.1007/s11060-025-05390-6. PMID: 41460384. Review; Meta-analysis˰ ˍ

Yaacov A, Gillis R, Salim J, Katz D, Asna N, Paldor I, Grinshpun A.
The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management.
Cells. 2025 Dec 29;15(1):57. doi: 10.3390/cells15010057. PMID: 41511341. Review. ˍ

Deng K, Huang J, Li D, Gao W, Wu M, Lei M.
Application Value and Research Frontiers of Immunotherapy in Glioblastoma: A Bibliometric and Visualized Analysis.
Oncol Res. 2025 Dec 30;34(1):20. doi: 10.32604/or.2025.069442. PMID: 41502522. Bibliometric analysis. ˍ

Cai L, Sun X, Li R, Ping Y, Lv S, Chen J.
Key methylation modifications in glioma stem cells.
Biochim Biophys Acta Rev Cancer. 2025 Dec 31;1881(1):189527. doi: 10.1016/j.bbcan.2025.189527. PMID: 41482238. Review˰ ˍ

Dubiński P, Odzimek-Rajska M, Podlewski S, Brola W.
Emerging Insights into the Role of the Microbiome in Brain Gliomas: A Systematic Review of Recent Evidence.
Int J Mol Sci. 2025 Dec 31;27(1):444. doi: 10.3390/ijms27010444. PMID: 41516317. Review. ˍ

Wu AC, Nakamura Y, Kiyotani K.
Advances in Neoantigen-Based Cancer Vaccines.
Cancers (Basel). 2025 Dec 31;18(1):144. doi: 10.3390/cancers18010144. PMID: 41514653. Review. ˍ